Litigation Details for Otsuka Pharmaceutical Co., Ltd. v. Optimus Pharma Pvt. Ltd. (D. Del. 2020)
✉ Email this page to a colleague
Otsuka Pharmaceutical Co., Ltd. v. Optimus Pharma Pvt. Ltd. (D. Del. 2020)
Docket | ⤷ Try a Trial | Date Filed | 2020-10-01 |
Court | District Court, D. Delaware | Date Terminated | |
Cause | 35:271 Patent Infringement | Assigned To | Leonard Philip Stark |
Jury Demand | None | Referred To | |
Patents | 10,307,419; 7,888,362; 8,349,840; 8,618,109; 9,839,637 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Otsuka Pharmaceutical Co., Ltd. v. Optimus Pharma Pvt. Ltd.
Details for Otsuka Pharmaceutical Co., Ltd. v. Optimus Pharma Pvt. Ltd. (D. Del. 2020)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2020-10-01 | 1 | Complaint | ,839,637 (“the ’637 patent”) and 10,307,419 (“the ’419 patent”). 24. In response to Optimus…the ’362 patent and U.S. Patent Nos. 8,349,840 (“the ’840 patent”), 8,618,109 (“the ’109 patent”), 9,839,637…civil action for patent infringement of U.S. Reissue Patent No. RE48,059 (“the RE’059 patent”), arising under…’362 patent as the RE’059 patent on June 23, 2020. A true and correct copy of the RE’059 patent is attached… The Patent In Suit 16. The United States Patent and Trademark Office ( | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |